|
| ID |
DDInter1544 |
| Drug Type |
small molecule |
| Molecular Formula |
C18H26Cln3O3 |
| Molecular Weight |
367.877
|
| Description |
Prucalopride is a P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST).
|
| ATC Classification |
A06AX05
|
| IUPAC Name |
4-Amino-5-Chloro-N-[1-(3-Methoxypropyl)Piperidin-4-Yl]-2,3-Dihydro-1-Benzofuran-7-Carboxamide |
| InChI |
Inchi=1S/C18H26Cln3O3/C1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/H11-12H,2-10,20H2,1H3,(H,21,23) |
| InChI Key |
ZPMNHBXQOOVQJL-UHFFFAOYSA-N |
| Canonical SMILES |
COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|